Other languages Island Pharmaceuticals Limited

Equities

ILA

AU0000138869

Market Closed - Australian S.E. Other stock markets 01:58:45 2024-06-28 am EDT			5-day change	1st Jan Change
0.077 ^AUD	+1.32%		-1.28%	-18.95%

May. 08	Island Pharmaceuticals Reallocates Grant Funding to Dengue Fever Trial; Shares Rally 13%	MT
Apr. 16	Island Pharmaceuticals Reports Positive Data from Dose Study of Dengue Medication	MT

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Island Pharmaceuticals Reallocates Grant Funding to Dengue Fever Trial; Shares Rally 13%	May. 07
Island Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended December 31, 2023	Feb. 25
Australia Shares Fall as Central Bank Keeps Rates Steady	Feb. 06
Island Pharmaceuticals Achieves Primary Endpoint in Dengue Drug Ascending Dose Study	Feb. 05
Island Pharmaceuticals Doses Subjects with Third Cohort for Dengue Medication Study	Jan. 18
Island Pharmaceuticals Signs R&D Loan Deal With Radium Capital	Dec. 15
Island Pharmaceuticals Announces Change of Company Secretaries	Nov. 30
Island Pharmaceuticals Administers First Drug Cohort for Dengue Medication Study	Nov. 24
Island Pharmaceuticals Begins Screening for Dengue Medication Study	Nov. 13
Island Pharmaceuticals Gets Nearly AU$390,000 R&D Tax Rebate; Shares Fall 4%	Nov. 09
Island Pharmaceuticals Secures Australian Patent for Flavivirus Treatment	Nov. 02
Island Pharmaceuticals Secures US Patent to Support Dengue Medication	23-09-13
Island Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-29
Island Pharmaceuticals Secures FDA Clearance for ISLA-101 Program for Mosquito-Borne Diseases	23-05-16
Island Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended December 31, 2022	23-02-22
Island Pharmaceuticals Ltd Receives Additional FDA Feedback on IND for ISLA-101 Phase 2a Clinical Study	23-01-31
Island Pharmaceuticals Receives US FDA Feedback for Upcoming Phase 2 Dengue Trial; Shares Fall 5%	23-01-20
Island Pharmaceuticals Submits IND Application to US FDA for Clinical Trial of Dengue Fever Drug Candidate	22-12-27
Island Pharmaceuticals Submits Investigational New Drug Application for ISLA-101 Clinical Trial	22-12-27
Island Pharmaceuticals Limited Announces Institutional Review Board Approval Receive for ISLA-101 Phase 2A Clinical Trial	22-12-14

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Island Pharmaceuticals Limited

Equities

ILA

AU0000138869

Other languages

Filters